Prelude Therapeutics Incorporated (PRLD)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20260 patents granted to the name below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Prelude Therapeutics Incorporated’s names, not what it holds today.
57 published
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Dec 4, 2025 | 2025/0367205 | Selective Inhibitors Of Protein Arginine Methyltransferase 5 (PRMT5) | Pharmaceuticals | Prelude Therapeutics Incorporated |
| Nov 27, 2025 | 2025/0361258 | PROCESSES FOR MAKING PRMT5 INHIBITORS | Organic fine chemistry | Prelude Therapeutics Incorporated |
| Sep 11, 2025 | 2025/0281473 | CDK Inhibitors And Their Use As Pharmaceuticals | Pharmaceuticals | Prelude Therapeutics Incorporated |
| Sep 4, 2025 | 2025/0276074 | BRM AND BRG1 TARGETING ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF | Pharmaceuticals | Prelude Therapeutics Incorporated |
| Jun 19, 2025 | 2025/0197418 | Polymorphic Compounds And Uses Thereof | Pharmaceuticals | Prelude Therapeutics Incorporated |
| May 22, 2025 | 2025/0163074 | CDK Inhibitors And Their Use As Pharmaceuticals | Organic fine chemistry | Prelude Therapeutics Incorporated |
| May 22, 2025 | 2025/0161289 | KAT6 Targeting Compounds | Pharmaceuticals | Prelude Therapeutics Incorporated |
| Apr 10, 2025 | 2025/0114354 | COMBINATION TREATMENT REGIMENS - SMARCA2 DEGRADER WITH PD-1 INHIBITORS | Pharmaceuticals | Prelude Therapeutics Incorporated |
| Apr 10, 2025 | 2025/0114353 | Combination Treatment Regimens - SMARCA2 Degrader With Gemcitabine | Pharmaceuticals | Prelude Therapeutics Incorporated |
| Mar 6, 2025 | 2025/0074916 | BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE | Organic fine chemistry | Prelude Therapeutics Incorporated |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.